Latest Headlines

Latest Headlines

More counterfeits of Roche cancer drugs surface in Europe

Counterfeiters in Europe are displaying a fondness for mimicking high-priced Roche cancer drugs. For the second time in 5 months, authorities there have uncovered fakes, and the two cases appear not to be connected.

Hunt for next Sovaldi leads to $150M deal, Poxel raises €10M, AbbVie backs AM-Pharma round

In this week's EuroBiotech Report, the search for the drug that can do to hepatitis B what Sovaldi does to hepatitis C led OnCure BioPharma to Sweden to strike a $150 million (€116 million) deal with NeuroVive Pharmaceutical. And more.

Lilly and Boehringer snag EU nod for Lantus knockoff, but stateside hopes stay on ice

Eli Lilly and Boehringer Ingelheim won European clearance for their biosimilar of Lantus, Sanofi's top-selling insulin product, but the treatment's full potential remains hamstrung by a U.S. patent challenge.

EU creates €1B fund for research on the use of graphene

The European Union is betting heavily on graphene, a potential material of the future with several med tech applications, via a €1 billion ($1.3 billion) research fund dubbed the Graphene Flagship.

AZ strikes Alderley cancer pact, Cerenis mulls IPO, 4D to start microbiome trials in 2015

In this week's EuroBiotech Report, having spent much of 2014 touting the potential of its clinical-stage oncology candidates, AstraZeneca struck a deal with Redx Pharma to work on the next generation of cancer drugs. And more.

Sources: West Pharmaceutical looks at $130M investment in Ireland

Pennsylvania-based West Pharmaceutical is again looking east for expansion. The maker of glass products for the pharma biz, which recently opened a plant in India, is now looking at adding a facility in Ireland that could run to €100 million.

Bayer's startup accelerator funds 5 device, healthcare app companies

Fresh off the sales of its interventional device unit to Boston Scientific, Bayer Healthcare is showing renewed interest in med tech via its startup accelerator.

Ex-Shire exec starts at Cortendo, Innate gets orphan nod, Ablynx trims in preclinical

In this week's EuroBiotech Report, with AstraZeneca now back in play--if it chooses--talk of M&A involving European drugmakers has ratcheted up once again after a brief, post-Shire lull. And more.

Medtronic expands hospital services push with $350M acquisition

Medtronic  wants to be known for manufacturing high-quality devices and providing related services as well. To that end, the company today announced the acquisition of privately held Italian company NGC Medical S.p.A.

Recipharm buys into Italy with $165M CMO deal

Swedish contract developer Recipharm is looking to expand its share of the European manufacturing market, trading $164.5 million for Italy's Corvette Pharmaceutical Services.